Pfizer invests $350m in new biosimilar project in China

05-07-2016

Pfizer invests $350m in new biosimilar project in China

StockStudio / Shutterstock.com

Pfizer has revealed that it will invest approximately $350 million to develop a Global Biotechnology Center in China.


Pfizer, Global Technology Center, HEDA, biosimilar

LSIPR